Stimulation of Erythropoiesis by Androgenic Hormones
Authors: B. J. KENNEDY
Journal: Annals of Internal Medicine (1962)

Article1 December 1962Stimulation of Erythropoiesis by Androgenic HormonesB. J. KENNEDY, M.D., F.A.C.P.B. J. KENNEDY, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-57-6-917 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAn increase in erythropoiesis has been observed repeatedly following administration of androgenic hormones in animals and man (1, 2). The most extensive observations in man have been made during the hormonal therapy of advanced breast cancer (1-15). Alterations of erythropoietic activity consisted of an increase in hemoglobin, hematocrit level, and red blood cell count, and hyperplasia of the erythroid elements of the bone marrow. The observations supported the concept that androgenic hormones are a specific stimulating factor of erythropoiesis. It was suggested that male hormone therapy be employed in the treatment of various refractory anemias (2, 16, 17). Because of...References1. KENNEDYGILBERTSEN BJAS: Increased erythropoiesis induced by androgenic hormones. J. Clin. Invest. 35: 717, 1956. Google Scholar2. KENNEDYGILBERTSEN BJAS: Increased erythropoiesis induced by androgenic hormone therapy. New Engl. J. Med. 256: 719, 1957. CrossrefMedlineGoogle Scholar3. KENNEDYTIBBETTSNATHANSONAUB BJDMITJC: Chemical and systemic changes in patients with advanced carcinoma of breast following hormonal therapy and castration. Cancer Res. 9: 551, 1949. Google Scholar4. ESCHER G: Clinical improvement of inoperable breast carcinoma under steroid treatment, in Proceedings of First Conference on Steroid Hormones and Mammary Cancer Sponsored by the Therapeutic Trials Committee of the Council on Pharmacy and Chemistry of the American Medical Association, American Medical Association, Chicago, 1949, p. 92. Google Scholar5. KENNEDY BJ: Side effects of large doses of estrogens and androgens in mammary cancer, in Proceedings of First Conference on Steroid Hormones and Mammary Cancer Sponsored by the Therapeutic Trials Committee of the Council on Pharmacy and Chemistry of the American Medical Association, American Medical Association, Chicago, 1949, p. 111. Google Scholar6. TALBOTESCHER TRGC: Effects of testosterone propionate on peripheral blood and bone marrow of women with advanced inoperable carcinoma of breast: preliminary report. J. Clin. Endocr. 9: 666, 1949. Google Scholar7. ADAIRMELLORSFARROWWOODARDESCHERURBAN FERCJHHAGCJA: The use of estrogens and androgens in advanced mammary cancer: clinical and laboratory study of one hundred and five female patients. JAMA 140: 1193, 1949. CrossrefMedlineGoogle Scholar8. : Current status of hormone therapy of advanced mammary cancer. JAMA 146: 471, 1951. MedlineGoogle Scholar9. BATEMAN JC: A study of blood volume and anemia in cancer patients. Blood 6: 639, 1951. CrossrefMedlineGoogle Scholar10. KENNEDYNATHANSON BJIT: Effects of intensive sex steroid hormone therapy in advanced breast cancer. JAMA 152: 1135, 1953. CrossrefMedlineGoogle Scholar11. GELLHORNHOLLANDHERMANNMOSSSMELIN AJJBJA: An evaluation of stanolone in treatment of advanced mammary cancer. JAMA 154: 1274, 1954. MedlineGoogle Scholar12. KENNEDYNATHANSONTIBBETTSAUB BJITDMJC: Biochemical alterations during steroid hormone therapy of advanced breast cancer. Amer. J. Med. 19: 337, 1955. CrossrefMedlineGoogle Scholar13. KENNEDY BJ: The effect of stanolonc in the treatment of advanced breast cancer. Cancer 8: 488, 1955. CrossrefMedlineGoogle Scholar14. KENNEDY BJ: Fluoxymesterone in the treatment of advanced breast cancer. Cancer 10: 813, 1957. CrossrefMedlineGoogle Scholar15. KENNEDY BJ: Fluoxymesterone in advanced breast cancer. New Engl. J. Med. 259: 673, 1958. CrossrefMedlineGoogle Scholar16. MCCULLAGHJONES EPTR: A note on the effect of certain androgens upon the red blood count and upon the glucose tolerance. Cleveland Clin. Quart. 8: 79, 1941. CrossrefGoogle Scholar17. MCCULLAGHJONES EPTR: Effect of androgens on blood count of men. J. Clin. Endocr. 2: 243, 1942. CrossrefGoogle Scholar18. GLASS SJ: Case of myxedema with macrocytic anemia successfully treated with thyroid and testosterone. J. Clin. Endocr. 3: 421, 1943. CrossrefGoogle Scholar19. ROSENTHALERF NLA: Clinical observations on osteopetrosis and myelofibrosis. Arch. Intern. Med. 71: 793, 1943. CrossrefGoogle Scholar20. ERFHERBUT LAPA: Primary and secondary myelofibrosis (a clinical and pathological study of thirteen cases of fibrosis of the bone marrow). Ann. Intern. Med. 21: 863, 1944. LinkGoogle Scholar21. WATKINSONMCMENEMEYEVANS GWHG: Hypopituitarism, hypogonadism, and anaemia: treated with testosterone. Lancet 1: 631, 1947. CrossrefMedlineGoogle Scholar22. DAUGADAYWILLIAMSDALAND WHRHGA: Effect of endocrinopathies on blood. Blood 3: 1342, 1948. CrossrefMedlineGoogle Scholar23. LAWRENCE JH: Symposium on the efficacy of new drugs: the treatment of chronic leukemia. Med. Clin. N. Amer. 38: 525, 1954. CrossrefGoogle Scholar24. SCOTTCARTWRIGHTWINTROBE JLGEMM: Acquired aplastic anemia: an analysis of thirty-nine cases and review of the pertinent literature. Medicine 38: 119, 1959. CrossrefMedlineGoogle Scholar25. SHAHIDIDIAMOND NTLK: Testosterone induced remission in aplastic anemia. Amer. J. Dis. Child. 98: 293, 1959. Google Scholar26. PRINGLEGARDNER JCFH: Treatment of myeloid metaplasia with testosterone. Clin. Res. 7: 210, 1959. Google Scholar27. SHAHIDIDIAMOND NTLK: Testosterone-induced remission in aplastic anemia of both acquired and congenital types. New Engl. J. Med. 264: 953, 1961. CrossrefMedlineGoogle Scholar28. GARDNERPRINGLE FHJC: Androgens and erythropoiesis. I. Preliminary clinical observations. Arch. Intern. Med. 107: 846, 1961. CrossrefMedlineGoogle Scholar29. GARDNERPRINGLE FHJC: Androgens and erythropoiesis. II. Treatment of myeloid metaplasia. New Engl. J. Med. 264: 103, 1961. CrossrefMedlineGoogle Scholar30. ADAMSSHEVKET AEF: The normal blood picture of white rats and the changes in the picture following thyroid feeding. Physiol. Zoo. 2: 181, 1929. CrossrefGoogle Scholar31. SCARBOROUGH RA: The blood picture of normal laboratory animals. Yale J. Biol. Med. 3: 63, 1930; 3: 169, 1930; 3: 267, 1931; 3: 359, 1931; 3: 431, 1931. MedlineGoogle Scholar32. STEINJACOBSEN KB: The effects of castration and cryptorchidization on the blood picture of the golden hamster. Anat. Rec. 88: 459, 1944. Google Scholar33. STEINGLASSGORDONCHARIPPER PASHA: Effect of castration and sex hormones on blood of rat. Proc. Soc. Exp. Biol. Med. 48: 169, 1941. CrossrefGoogle Scholar34. VOLLMERGORDON EPAS: Effect of sex and gonadotropic hormones upon blood picture of rat. Endocrinology 29: 828, 1941. CrossrefGoogle Scholar35. CRAFTS RC: Effects of hypophysectomy, castration and testosterone propionate on hemopoiesis in adult male rat. Endocrinology 39: 401, 1946. CrossrefMedlineGoogle Scholar36. VAN DYKECONTOPOULOSWILLIAMSSIMPSONLAWRENCEEVANS DCANBSMEJHHM: Hormonal factors influencing erythropoiesis. Acta Haemat. (Basel) 11: 203, 1954. CrossrefMedlineGoogle Scholar37. FERRARI R: Influenza della milza sulle variazioni determinate dalla castrazione e dal trapianto di gonadi eterosessuali nel numero degli eritrociti e dei leuciciti, nella quantità di emoglobina e nella formula leucocitaria. Haematologica 11: 421, 1930. Google Scholar38. STEINCARRIER KFE: Changes in erythrocytes of hamsters following castration, splenectomy and subsequent liver, iron, and testosterone injections. Proc. Soc. Exp. Biol. Med. 60: 313, 1945. CrossrefMedlineGoogle Scholar39. TABERDAVISDOMM EDELV: Effect of sex hormones on the erythrocyte number in the blood of the domestic fowl. Amer. J. Physiol. 138: 479, 1942. CrossrefGoogle Scholar40. ARVY L: Le retentissement de la castration sur l'hématopoïesè du coq domestique. Sang 15: 334, 1943. Google Scholar41. ARVY L: Le retentissement des injections de testosterone sur l'hématopoïesè du chapon. Sang 15: 328, 1943. Google Scholar42. FINKELSTEINGORDONCHARIPPER GASHA: The effect of sex hormones on the anemia induced by hemorrhage in the rat. Endocrinology 35: 267, 1944. CrossrefGoogle Scholar43. LARIZZANOTARIOCASIROLA PAG: Androgeni ed emopoiesi: ricerche sperimentali. Haematologica 35: 437, 1951. MedlineGoogle Scholar44. DEBIAS DA: Effect of testosterone propionate on red cell count in ovariectomized and ovariectomized-thyroidectomized rat. Amer. J. Physiol. 165: 476, 1951. CrossrefMedlineGoogle Scholar45. TYSLOWITZDINGEMANSE RE: Effect of large doses of estrogens on blood picture of dogs. Endocrinology 29: 817, 1941. CrossrefGoogle Scholar46. DUKESGOLDWASSER PPE: Estrogen inhibition of erythropoiesis. Endocrinology 69: 21, 1961. CrossrefMedlineGoogle Scholar47. GARDNER WU: Pelvic changes occurring in male mice receiving large amounts of folliculin benzoate. Proc. Soc. Exp. Biol. Med. 33: 104, 1935. CrossrefGoogle Scholar48. GARDNER WU: Sexual demorphism of the pelvis of the mouse, the effect of estrogenic hormones upon the pelvis and upon the development of scrotal hernias. Amer. J. Anat. 59: 459, 1936. CrossrefGoogle Scholar49. GARDNERPFEIFFER WUCA: Skeletal changes in mice receiving estrogens. Proc. Soc. Exp. Biol. Med. 37: 678, 1938. CrossrefGoogle Scholar50. WENTWORTHSMITHGARDNER JHPKWU: The composition of bones of mice receiving estrogens and androgens. Endocrinology 26: 61, 1940. CrossrefGoogle Scholar51. GARDNERPFEIFFER WUCA: Influence of estrogens and androgens on the skeletal system. Physiol. Rev. 23: 139, 1943. CrossrefGoogle Scholar52. MILLERORRPYBUS EWJWFC: The effect of estrone on the mouse skeleton with particular reference to the Newcastle bone tumor (NBT) strain. J. Path. Bact. 55: 137, 1943. CrossrefGoogle Scholar53. GARDNERPEIFFER WUCA: Inhibition of estrogenic effects on the skeleton by testosterone injections. Proc. Soc. Exp. Biol. Med. 38: 599, 1938. CrossrefGoogle Scholar54. PFEIFFERGARDNER CAWU: Skeletal changes and blood serum calcium levels in pigeons receiving estrogens. Endocrinology 23: 485, 1938. CrossrefGoogle Scholar55. ARNOLDHOLTZMARX OFH: Über Beziehungen der Sexualhormone zum Kalkstoffwechsel und zum Knochenmark. Naturweiss. 24: 314, 1936. CrossrefGoogle Scholar56. ARNOLD O: Über die Wirkung des synthetischen Brunststoffer Diäthylstilbostrol auf das Knochenmark und Blut des Hundes. Klin. Wschr. 18: 891, 1939. CrossrefGoogle Scholar57. MACBRYDECASTRODALEHELWIGBIERBAUMPOE CMDEBOJS: Effects of synthetic and natural estrogens on blood, liver, and bone marrow. J. Clin. Invest. 19: 773, 1940. Google Scholar58. CRAFTS RC: The effects of endocrines on the formed elements of the blood. II. The effect of estrogens in the dog and monkey. Endocrinology 29: 606, 1941. CrossrefGoogle Scholar59. CASTRODALEBIERBAUMHELWIGMACBRYDE DOEBCM: Comparative studies of the effects of estradiol and stilbestrol upon the blood, liver and bone marrow. Endocrinology 29: 363, 1941. CrossrefGoogle Scholar60. DOUGHERTYWILLIAMSGARDNER TFWLWU: Changes in the myeloid and lymphoid tissues of estrogen treated dogs. Anat. Rec. 85: 307, 1943. Google Scholar61. CRUZPIMENTA DE MELLODA SILBA WOREM: Estudos sobre anemia produzida em caes por benzoato de estradiol. Mem. Inst. Cruz 41: 168, 1944. Google Scholar62. CRAFTS RC: The effects of estrogens on the bone marrow of adult female dogs. Blood 3: 276, 1948. CrossrefMedlineGoogle Scholar63. POTS P: The effect of diethylstilbestrol diphosphate on hematopoiesis. Acta Endocr. (Kbh) supp. 51: 885, 1960. Google Scholar64. ASCHNER B: Über die Funktion der Hypophyse. Pflueger. Arch. Ges. Physiol. 146: 1, 1912. CrossrefGoogle Scholar65. HOUSSAYROGEROVIAS BAMO: Hemoglobina y globulos rojos en los perros hipofisoprivos. Rev. Soc. Argent. Biol. 7: 314, 1931. Google Scholar66. MEYERSTEWARDTHEWLISRUSCH OOGEEWHP: Hypophysis and hematopoiesis. Folia Haemat. (Frankf.) 59: 99, 1937. Google Scholar67. VOLLMERGORDONCHARIPPER EPASHA: Effects of hormones upon erythropoiesis in the hypophysectomized rat. Endocrinology 31: 619, 1942. CrossrefGoogle Scholar68. CRAFTS RC: Effects of iron, copper and thyroxine on anemia induced by hypophysectomy in adult female rat. Amer. J. Anat. 79: 267, 1946. CrossrefMedlineGoogle Scholar69. CRAFTS RC: Effects of high protein diet on anemia induced by hypophysectomy in adult female rats, including further details on post-hypophysectomy anemia. Endocrinology 45: 159, 1949. CrossrefMedlineGoogle Scholar70. GORDONCHARIPPER ASHA: The endocrine system and hemopoiesis. NY Acad. Sci. 48: 615, 1947. CrossrefGoogle Scholar71. WILLIAMSON CS: Influence of age and sex on hemoglobin. Arch. Intern. Med. 18: 505, 1916. CrossrefGoogle Scholar72. RUD EJ: Le nombre des globules rouges chez les siyets normaux et leurs variations dans les diverses conditions physiologiques. Acta Med. Scand. 57: 142, 1922. CrossrefGoogle Scholar73. OSGOODBAKER EERL: Erythrocyte, hemoglobin, cell volume and color, volume and saturation index standards for normal children of school age. Amer. J. Dis. Child. 50: 343, 1935. Google Scholar74. HAWKINSSPECKLEONARD WWEVG: Variation of hemoglobin level with age and sex. Blood 9: 999, 1954. CrossrefMedlineGoogle Scholar75. WINTROBE MM: Clinical Hematology, Lea & Febiger, Philadelphia, 1961, p. 105. Google Scholar76. PONDER E: The Mammalian Red Cell and the Properties of the Haemolytic Systems, Gebruder Bromtraeger, Berlin, 1934. Google Scholar77. OLBRICH O: Blood changes in the aged. Edinburgh Med. J. 54: 306, 1947. MedlineGoogle Scholar78. VAHLQUIST B: Cause of sexual differences in erythrocyte, hemoglobin and serum iron levels in human adults. Blood 5: 874, 1950. CrossrefMedlineGoogle Scholar79. BERLINHYDEPARSONSLAWRENCEPORT NIGMRJJHS: Blood volume of the normal female as determined with P32 labeled red blood cells. Proc. Soc. Exp. Biol. Med. 76: 831, 1951. CrossrefMedlineGoogle Scholar80. HEDLUND S: Studies on erythropoiesis and total red cell volume in congestive heart failure. Acta Med. Scand. supp. 284, 1953. Google Scholar81. WADSWORTH GR: Blood volume of normal women. Blood 9: 1205, 1954. CrossrefMedlineGoogle Scholar82. GRIFFINHAINES HZSF: A review of a group of professional donors. JAMA 81: 532, 1923. CrossrefGoogle Scholar83. MARTINMYERS JWJT: The effects of blood transfusions of donors. J. Lab. Clin. Med. 20: 593, 1934-5. Google Scholar84. FOWLERBARER WMAP: Rate of hemoglobin regeneration in blood donors. JAMA 118: 421, 1942. CrossrefGoogle Scholar85. CHEVALLIERUMDENSTOCK PR: Myelophtisie mortelle après injections de benzoate d'oestradiol (folliculine cristallisée) à hautes doses chez une femme atteinte de prurit vulvaire sine materia. Sang 15: 528, 1942-43. Google Scholar86. LORING TW: Aplastic anemia during pregnancy. Stanford Med. Bull. 11: 170, 1953. MedlineGoogle Scholar87. DILWORTHMAYS EECR: Clinical and hematological aplastic anemia with hypocellular marrow in pregnancy. Amer. J. Obstet. Gynec. 54: 529, 1947. CrossrefMedlineGoogle Scholar88. BERLINHYDEPARSONSLAWRENCE NIGMRJJH: Medical progress. The blood volume in various medical and surgical conditions. New Engl. J. Med. 247: 675, 1952. CrossrefMedlineGoogle Scholar89. LEHNHOFF HJ: Androgen therapy for refractory anemia: report of a case associated with thymoma. Ann. Intern. Med. 53: 1059, 1960. LinkGoogle Scholar90. WYATTSOMMERS JPC: Chronic marrow failure, myelosclerosis, and extramedullary hematopoiesis. Blood 5: 329, 1950. CrossrefMedlineGoogle Scholar91. SHANBROMFINCH ESE: Adverse effects of methyltestosterone in lymphoma. Cancer 10: 964, 1957. CrossrefMedlineGoogle Scholar92. WOLFF JA: Anemias caused by infections and toxins, idiopathic aplastic anemia and anemia caused by renal disease. Pediat. Clin. N. Amer. 4: 469, 1957. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Minneapolis, MinnesotaFrom the Department of Internal Medicine of the University of Minnesota Medical Center, Minneapolis, Minnesota.This research was supported by a research grant, CY3143, from the National Cancer Institute, National Institutes of Health, United States Public Health Service.Presented at the Forty-third Annual Session of The American College of Physicians, April 9-13, 1962, Philadelphia, Pennsylvania.Requests for reprints should be addressed to B. J. Kennedy, M.D., Department of Internal Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByEffects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal MenTestosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased RiskThe role of iron in mediating testosterone's effects on erythropoiesis in miceProspective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender IncongruenceErythrocytosis Following Testosterone TherapyAdult-Onset HypogonadismErythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging MaleHematologic Aspects of Malignant Lymphoproliferative DiseaseComparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trialA prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancerStimulation der H�matopoese zur Beschleunigung der Regeneration nach zytostatisch bedingter KnochenmarksdepressionStimulation of Hemopoiesis in Aplastic Anemia by Hormones and Other AgentsRELATIONSHIP BETWEEN HAEMOGLOBIN AND SERUM TESTOSTERONE IN NORMAL CHILDREN AND ADOLESCENTS AND IN BOYS WITH DELAYED PUBERTYThe use of androgens in the treatment of diseases of the hematopoietic systemAplastic anaemia in childrenHemopoietic response to male hormone in the chequered water-snake, Natrix piscatorEffect of the Anabolic Protein Hormone Prolactin on Human ErythropoiesisDie Panmyelopathie und andere Formen der PancytopenieDas Myelofibrose-SyndromThe Hematologic Effect of Androgen in Uremic Patients Study of Packed Cell Volume and Erythropoietin ResponsesWALTER FRIED, M.D., OLGA JONASSON, M.D., GORDON LANG, M.D., FRANKLIN SCHWARTZ, M.D., F.A.C.P.Improvement in the Anemia of Chronic Renal Failure with FluoxymesteroneJOSEPH W. ESCHBACH, M.D., F.A.C.P., JOHN W. ADAMSON, M.D.The Erythropoietic Response to Anabolic Therapy in Patients Receiving RadiotherapyErythropoietic Response of Dialyzed Patients to Testosterone AdministrationJOHN R. RICHARDSON JR., M.D., MORTON B. WEINSTEIN, M.D.Interactions between Androgenic-Anabolic Steroids and GlucocorticoidsPolyglobulie und Polycythaemia veraERYTHROPOIETINHormoneinwirkung auf die Proliferationskinetik humaner KnochenmarkkulturenTHE INTERRELATIONSHIPS OF THE ENDOCRINE AND ERYTHRO-POIETIC SYSTEMS IN THE RAT WITH SPECIAL REFERENCE TO THE MECHANISM OF ACTION OF ESTRADIOL AND TESTOSTERONETHE MECHANISM OF ACTION OF ANDROGENS ON ERYTHROPOIESISTHE EFFECT OF TESTOSTERONE ON THE UPTAKE OF TRITIATED THYMIDINE BY THE BONE MARROW OF CHILDRENErythropoese und ErythrocytenumsatzHormonal Syndromes Associated with NeoplasiaBibliographyEffect of Testosterone Treatment and Hypophysectomy on the Leucocyte Count in Irradiated RatsAnabolic Agents and Relative PolycythaemiaAlteration of iron metabolism during androgen therapy of advanced breast cancerClassification of Polycythemic Disorders With Comments on the Diagnostic Value of Arterial Blood Oxygen AnalysisJOHN F. MURRAY, M.D.CHAPTER 1: HEMATOLOGICAL DATA AND CLINICAL ACTIVITY OF THE RHEUMATOID DISEASECHRONIC RENAL INSUFFICIENCY TREATED WITH ANABOLIC STEROIDS: EFFECTS ON ACID-BASE BALANCE, PROTEIN METABOLISM AND HEMATOPOIESIS*Effects of Combined Hormone Therapy on Erythropoiesis in the Intact RabbitPolycythemiaSYSTEMIC EFFECTS OF ANDROGENIC AND ESTROGENIC HORMONES IN ADVANCED BREAST CANCER*The Syndromes of Obesity and of Delayed Growth in AdolescenceZur Fanconi-An�mie (FA)Einfluß eines anabolen Steroids auf die cytostatisch gehemmte Antikörperbildung bei der RatteAnabolic Steroids 1 December 1962Volume 57, Issue 6Page: 917-936KeywordsAnemiaBone marrowErythropoiesisHemoglobinHormonal therapyHormonesPolycythemiaPrevention, policy, and public healthRed blood cellsResearch grants Issue Published: 1 December 1962 PDF DownloadLoading ...